Schedule 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 13G

 

 

Under the Securities Exchange Act of 1934

 

 

 

 

 

Arbios Systems, Inc.


(Name of Issuer)

 

 

Common Stock, $.001 par value


(Title of Class of Securities)

 

 

03875V 10 7


                                (CUSIP Number)                                

 

 

October 30, 2003


(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

 

x Rule 13d-1(c)

 

¨ Rule 13d-1(d)

 

 

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

1


SCHEDULE 13G

 

CUSIP No. 03875V 10 7

 


  1.  

Name of Reporting Person

 

Cedars-Sinai Medical Center

 

I.R.S. Identification No. of Above Person (Entities Only)

 

95-1644600

   

  2.  

Check the Appropriate Box if a Member of a Group*

(a)  ¨

(b)  x

   

  3.  

SEC Use Only

 

   

  4.  

Citizenship or Place of Organization

 

California

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  5.    Sole Voting Power

 

        681,818


  6.    Shared Voting Power

 

        0


  7.    Sole Dispositive Power

 

        681,818


  8.    Shared Dispositive Power

 

        0


  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

681,818

   

10.  

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*

 

¨

   

11.  

Percent of Class Represented by Amount in Row (9)

 

5.2%

   

12.  

Type of Reporting Person*

 

CO

   

 

2


SCHEDULE 13G

 

This Statement on Schedule 13G relates to shares of common stock, par value $.001 per share (the “Common Stock”), of Arbios Systems, Inc., a Nevada corporation (the “Issuer”).

 

 

Item 1(a)      

   Name of Issuer: Arbios Systems, Inc.          

1(b)      

   Address of Issuer’s Principal Executive Offices:          
    

110 North George Burns Road #D-4018

Los Angeles, CA 90048

         

Item 2(a)-(c)

   The corporation filing this statement (a “Reporting Person”) is Cedars-Sinai Medical Center (“Cedars”), a California nonprofit public benefit corporation.  Reporting Person has an office at 8700 Beverly Boulevard, Los Angeles, California 90048.          

2(d)      

   Title of Class of Securities:          
    

Common Stock,  Par Value $.001per share

         

2(e)      

   CUSIP Number:    03875V 10 7          

Item 3           

   If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:     
     (a)    ¨    Broker or Dealer registered under Section 15 of the Exchange Act          
     (b)    ¨    Bank as defined in Section 3(a)(6) of the Exchange Act          
     (c)    ¨    Insurance company as defined in Section 3(a)(19) of the Exchange Act          
     (d)    ¨    Investment company registered under Section 8 of the Investment Company Act of 1940          
     (e)    ¨    An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E)          
     (f)    ¨    An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F)          
     (g)    ¨    A parent holding company or control person in accordance with Rule 13d-1(b)(ii)(G)          
     (h)    ¨    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act          
     (i)    ¨    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940          
     (j)    ¨    Group, in accordance with Rule 13d-1(b)(1)(ii)(J)          

Item 4

   Ownership          
          Cedars-Sinai Medical Center currently owns 681,818 shares of Common Stock. This represents 5.2% of the 13,150,598 shares of Common Stock deemed to be outstanding.          

Item 5

   Ownership of Five Percent or Less of a Class     
          Not Applicable

Item 6

   Ownership of More than Five Percent on Behalf of Another Person          
          Not Applicable          

 

3


Item 7

   Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company
         

Not Applicable

         

Item 8

   Identification and Classification of Members of the Group          
          Not Applicable          

Item 9

   Notice of Dissolution of Group          
          Not Applicable          

Item 10

   Certification          

 

By signing below, the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Exhibits

 

None

 

4


SIGNATURES

 

After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement on Schedule 13G is true, complete and correct.

 

Dated: November 12, 2003

CEDARS-SINAI MEDICAL CENTER

By:

 

/s/    Edward M. Prunchunas         


   

Edward M. Prunchunas

Senior Vice President for Finance and

Chief Financial Officer

 

5